Abstract
Inhibitory GABAA receptor ion channels are the target for a wide range of clinically-used therapeutic agents. The complex structural diversity of these ligand-gated channels, revealed by molecular cloning studies, together with increasing requirements for higher-throughput functional assays in drug discovery, has led to the development of a wide range of techniques to examine GABAA receptor pharmacology and function. In the current article we review some of the methodologies which have contributed to the expansion of knowledge in this field. The techniques include: molecular approaches, immunoprecipitation, and immunopurification to study receptor assembly, structure, and functional expression; in situ hybridization, immunocytochemistry, and autoradiography to examine receptor distribution in native tissues; radioligand binding, site-directed mutagenesis, and electrophysiology to examine pharmacology and allosteric modulation; and patch clamp, ion flux, microphysiometry, and a variety of novel fluorescence-based technologies to examine ion-channel function. The use of gene targetting approaches in transgenic mice has also provided important insights into the role of specific GABAA receptor subtypes in vivo. The continuing evolution of novel technologies and assay approaches with appropriate sensitivity and resolution to measure subtle modulation of GABAA ion channels will facilitate ongoing investigation of the physiological functions of these important inhibitory receptors.
Similar content being viewed by others
References
Sieghart W (1995) Pharmacol Rev 47:181–234
Mehta AK, Ticku MK (1999) Brain Res Rev 29:196–217
Schofield PR, Darlinson MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Nature 328:221–227
Macdonald R, Barker JL (1978) Nature 271:563–564
Morrow AL, Paul SM (1988) J Neurochem 50:302–306
Rabow LE, Russek SJ, Farb DH (1995) Synapse 21:189–274
Whiting PJ, Bonnert TP, McKernan RM, Farrar S, Bourdelles BL, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji DJ, Thompson SA, Wafford KA (1999) Ann NY Acad Sci 868:645–653
McKernan RM, Whiting PJ (1996) 19:139–143
Barnard EA, Skolnick P, Olson RW, Möhler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ, (1998) Pharmacol Rev 50:291–313
Martin DL, Olsen RW (2000) GABA in the nervous system: the view at fifty years, 1st edn. Philadelphia Lippincott Williams and Wilkins
Olsen RW, Macdonald RL (2002) GABAA receptor complex: structure and function. In: Krogsgaard-Larsen P, Egeberg J, Schousboe A (eds) Glutamate and GABA receptors and transporters: structure function and pharmacology. Taylor and Francis, London, pp 202–235
Sieghart W, Sperk G (2002) Curr Top Med Chem 2:795–816
Bollan K, King D, Robertson LA, Brown K, Taylor PM, Moss SJ, Connolly CN (2003) J Biol Chem 278:4747–4755
Wisden W, Herb A, Wieland H, Keinanen K, Luddens H, Seeburg PH (1991) FEBS 289:227–230
Fritschy J-M, Mohler H (1995) J Comp Neurol 359:154–194
Im WB, Pregenzer JF, Binder JA, Dillon GH, Alberts GL (1995) J Biol Chem 270:26063–26066
Farrar SJ, Whiting PJ, Bonnert TP, McKernan RM (1999) J Biol Chem 274:10100–10104
Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) J Neurosci 12:1040–1062
Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) Neuroscience 101:815–850
Korpi ER, Seeburg PH, Luddens H (1996) J Neurochem 66:2179–2187
Sur C, Fresu L, Howell O, McKernan RM, Atack JR (1999) Brain Res 822:265–270
Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Hoger H, Adamiker D (1999) Neurochem Int 34:379–385
Sigel E, Barnard EA (1984) J Biol Chem 259:7219–7223
Duggan MJ, Pollard S, Stephenson FA (1991) J Biol Chem 266:24778–24784
Quirk K, Gillard NP, Ragan CI, Whiting PJ, McKernan RM (1994) J Biol Chem 269:16020–16028
Bonnert TP, McKernan RM, Farrar S, Le Bourdelles B, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji DJS, Brown N, Wafford KA, Whiting PJ (1999) Proc Natl Acad Sci USA 96:9891–9896
Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, Seeburg PH (1989) Nature 338:582–585
Chang Y, Wang R, Barot S, Weiss DS (1996) J Neurosci 16:5415–5424
Cromer BA, Morton CJ, Parker MW (2002) TIBS 27:280–287
Brejc K Van Dijk WJ, Klaassen RV, Schuurmans M, Van der Oost J, Smit AB, Sixma TK (2001) Nature 411:269–276
Kash TL, Jenkins A, Kelley JC, Trudell JR, Harrison NL (2003) Nature 421:272–275
Pritchett DB, Luddens H, Seeburg PH (1989) Science 245:1389–1392
Hadingham KL, Harkness PC, McKernan RM, Quirk K, Le Bourdelles B, Horne AL, Kemp JA, Barnard EA, Ragan CI, Whiting PJ (1992) Proc Natl Acad Sci USA 89:6378–6382
Sur C, Quirk K, Dewar D, Atack J, McKernan RM (1998) Mol Pharmacol 54:928–933
McKernan RM, Farrar S, Collins I, Emms F, Asuni A, Quirk K, Broughton H (1998) Mol Pharmacol 54:33–43
Ebert B, Thompson SA, Saounatsou K, McKernan R, Krogsgaard-Larsen P, Wafford K (1997) Mol Pharmacol 52:1150–1156
Smith GB, Olsen RW (1995) TIPS 16:162–168
Wingrove PB, Thompson SA, Wafford KA, Whiting PJ (1997) Mol Pharmacol 52:874–881
Hadingham KL, Wingrove PB, Wafford KA, Bain C, Kemp JA, Palmer KJ, Wilson AW, Wilcox AS, Sikela JM, Ragan CI, Whiting PJ (1993) Mol Pharmacol 44:1211–1218
Buhr A, Baur R, Malherbe P, Sigel E (1996) Mol Pharmacol 49:1080–1084
Buhr A, Baur R, Sigel E (1997) J Biol Chem 272:11799–11804
Buhr A, Schaerer MT, Baur R, Sigel E (1997) Mol Pharmacol 52:676–682
Amin J, Brooks-Kayal AR, Weiss DS (1997) Mol Pharmacol 51:833–841
Schaerer MT, Buhr A, Baur R, Sigel E (1998) Eur J Pharmacol 354:283–287
Wieland HA, Lüddens H, Seeburg PH (1992) J Biol Chem 267:1426–1429
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996) Mol Pharmacol 50:670–678
Knoflach F, Benke D, Wang Y, Scheurer L, Luddens H, Hamilton BJ, Carter DB, Mohler H, Benson JA (1996) Mol Pharmacol 50:1253–1261
Benke D, Honer M, Michel C, Mohler H (1996) Neuropharmacology 35:1413–1423
Wafford KA, Bain CJ, Whiting PJ, Kemp JA (1993) Mol Pharmacol 44:437–442
Hadingham KL, Wafford KA, Thompson SA, Palmer KJ, Whiting PJ (1995) Eur J Pharmacol Mol Pharm Sect 291:301–309
Carlson BX, Engblom AC, Kristiansen U, Schousboe A, Olsen RW (2000) Mol Pharmacol 57:474–484
Cestari IN, Min KT, Kulli JC, Yang J (2000) J Neurochem 74:827–838
Wingrove PB, Wafford KA, Bain C, Whiting PJ (1994) Proc Natl Acad Sci USA 91:4569–4573
Belelli D, Lambert JL, Peters JA, Wafford K, Whiting PJ (1997) Proc Natl Acad Sci USA 94:11031–11036
Mohler H, Richards JG (1981) Nature 294:763–765
Skerritt JH, Willow M, Johnston GAR (1982) Neurosci Lett 29:63–66
Luddens H, Seeburg PHS, Korpi ER (1994) Mol Pharmacol 45:810–814
Liljequist S, Tabakoff B (1993) J Pharmacol Exp Ther 264:638–647
Edwards FA, Konnerth A, Sakmann B (1990) J Physiol 430:213–249
Choi DW, Farb DH, Fischbach GD (1977) Nature 269:342–344
Thompson SA, Whiting PJ, Wafford KA (1996) Br J Pharmacol 117:521–527
Krasowski MD, Nishikawa K, Nikolaeva N, Lin A, Harrison NL (2001) Neuropharmacology 41:952–964
Buhr A, Wagner C, Fuchs K, Sieghart W, Sigel E (2001) J Biol Chem 276:7775–7781
Engblom AC, Carlson BX, Olsen RW, Schousboe A, Kristiansen U (2002) J Biol Chem 277:17438–17447
Levitan ES, Schofield PR, Burt DR, Rhee LM, Wisden W, Kohler M, Fujita N, Rodriguez HF, Stephenson A, Darlinson MG (1988) Nature 335:76–79
Porter NM, Angelotti TP, Twyman RE, MacDonald RL (1992) Mol Pharmacol 42:872–881
Harris RA, Mihic SJ, Brozowski S, Hadingham K, Whiting PJ (1997) Alcohol Clin Exp Res 21:444–451
Ebert V, Scholze P, Sieghart W (1996) Neuropharmacology 35:1323–1330
Eghbali M, Curmi JP, Birnir B, Gage PW (1997) Nature 388:71–75
Lachnit WG, Costantin JL (2002) Drug Discovery Today 7:651–652
Schroeder K, Neagle B, Trezise DJ, Worley J (2003) J Biomol Screening 8:50–64
Kardos J (1993) Synapse 13:74–93
Javors MA, King TS, Chang X, Ticku MK, Levinson C (1998) Brain Res 780:183–189
Allan AM, Harris RA (1986) Mol Pharmacol 29:497–505
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR (2001) Mol Pharmacol 59:1108–1118
McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG, Pitchford S (1992) Science 257:1906–1912
Brown MJ, Wood MD, Coldwell MC, Bristow DR (1997) Br J Pharmacol 121:71–76
Smith AJ, McKernan RM, Atack JR (1998) Eur J Pharmacol 359:261–269
Kaila K, Voipio J (1987) Nature 330:163–165
Verkman AS (1990) Am J Physiol 259:C375–C388
Biwersi J, Verkman AS (1991) Biochemistry 30:7879–7883
Engblom AC, Akerman KEO (1993) Biochim Biophys Acta 1153:262–266
Marandi N, Konnerth A, Garaschuk O (2002) Pflugers Arch 445:357–365
Simpson PB, Woollacott AJ, Pillai GV, Maubach KA, Hadingham KL, Martin K, Choudhury HI, Seabrook GR, (2000) J Neurosci Methods 99:91–100
Kuner T, Augustine GJ (2000) Neuron 27:447–459
Gonzalez JE, Oades K, Leychkis Y, Harootunian A, Negulescu PA (1999) Drug Discovery Today 4:431–439
Adkins CE, Pillai GV, Kerby J, Bonnert TP, Haldon C, McKernan RM, Gonzalez JE, Oades K, Whiting PJ, Simpson PB (2001) J Biol Chem 276:38934–38939
Pillai GV, Smith AJ, Simpson PB (2002) FENS Abstr 1:A078.14
Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA (2002) Br J Pharmacol 136:965–974
Wohlfarth KM, Bianchi MT, Macdonald RL (2002) J Neurosci 22:1541–1549
Baxter DF, Kirk M, Garcia AF, Raimondi A, Holmqvist MH, Flint KK, Bojanic D, Distefano PS, Curtis R, Xie Y, (2002) J Biomol Screening 7:79–85
Rudolph U, Crestani F, Mohler H (2001) TIPS 22:188–194
Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy J-M, Martin JR, Bluethmann H, Möhler H, (1999) Nature 401:796–800
McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ (2000) Nat Neurosci 3:587–592
Sur C, Wafford KA, Reynolds DS, Hadingham KL, Bromidge F, Macaulay A, Collinson N, O'Meara G, Howell O, Newman R, Myers J, Atack JR, Dawson GR, McKernan RM, Whiting PJ, Rosahl TW (2000) J Neurosci 21:3409–3418
Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi Z-P, Lagenaur C, Tretter V, Sieghart W, Anagnostaras G, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, DeLorey TM, Olsen RW, Homanics GE (1999) Proc Natl Acad Sci USA 96:12905–12910
DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, Minassian BA, Asatourian A, Fanselow MS, Delgado-Escueta A, Ellison GD, Olson RW (1998) J Neurosci 18:8505–8514
Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent JP, Belzung C, Fritschy J-M, Luscher B, Möhler H (1999) Nat Neurosci 2:833–839
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, A.J., Simpson, P.B. Methodological approaches for the study of GABAA receptor pharmacology and functional responses. Anal Bioanal Chem 377, 843–851 (2003). https://doi.org/10.1007/s00216-003-2172-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-003-2172-y